tiprankstipranks
Trending News
More News >
Clover Corporation Limited (AU:CLV)
ASX:CLV
Advertisement

Clover Corporation Limited (CLV) AI Stock Analysis

Compare
10 Followers

Top Page

AU:CLV

Clover Corporation Limited

(Sydney:CLV)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
AU$1.00
▲(19.05% Upside)
Clover Corporation Limited has a strong financial foundation with robust revenue growth and profitability. The technical indicators suggest bullish momentum, though caution is advised due to overbought signals. The valuation is fair, providing a balanced risk-reward profile.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.
Balance Sheet Health
A low debt-to-equity ratio reflects minimal leverage, reducing financial risk and enhancing the company's ability to invest in growth opportunities.
Profitability Margins
Strong profitability margins suggest effective cost management and operational efficiency, contributing to sustained financial health and competitive advantage.
Negative Factors
Decline in Free Cash Flow Growth
A significant decline in free cash flow growth can limit the company's ability to reinvest in the business, potentially impacting future growth and financial flexibility.
Limited Earnings Call Data
Lack of earnings call data may hinder transparency and investor confidence, affecting the company's ability to communicate strategic initiatives and financial performance.
Lack of Corporate Events
Absence of corporate events could indicate a lack of strategic initiatives or partnerships, potentially impacting the company's growth prospects and market positioning.

Clover Corporation Limited (CLV) vs. iShares MSCI Australia ETF (EWA)

Clover Corporation Limited Business Overview & Revenue Model

Company DescriptionClover Corporation Limited (CLV) is an innovative company based in Australia, specializing in the development and manufacturing of high-quality food ingredients, particularly focused on natural coloring and flavoring solutions. The company operates primarily in the food and beverage sector, providing products that enhance the visual appeal and taste of various consumables. Clover Corporation is known for its expertise in food science and technology, offering a range of products including natural colorants derived from plant sources, which cater to the growing demand for clean label and healthy food options.
How the Company Makes MoneyClover Corporation generates revenue through the sale of its food ingredient products, particularly natural colorants and flavor enhancers. The company’s revenue model is based on direct sales to food manufacturers and distributors, which allows it to reach a broad customer base across various segments including confectionery, dairy, and beverages. Key revenue streams include bulk sales of colorants, customized formulations for specific customer needs, and ongoing research and development collaborations with industry partners. Additionally, Clover may benefit from strategic partnerships with larger food companies that seek to enhance their product offerings with natural ingredients, further contributing to its earnings.

Clover Corporation Limited Financial Statement Overview

Summary
Clover Corporation Limited shows strong financial health with impressive revenue growth and profitability margins. The balance sheet is robust with low leverage, enhancing financial stability. However, the significant decline in free cash flow growth could pose a risk if not addressed.
Income Statement
85
Very Positive
Clover Corporation Limited has demonstrated strong revenue growth of 18.64% in the latest year, with improving gross profit and net profit margins at 30.43% and 8.16%, respectively. The EBIT and EBITDA margins also show a healthy profitability trend at 12.42% and 14.23%. This indicates a robust financial performance with effective cost management and operational efficiency.
Balance Sheet
78
Positive
The company's balance sheet is solid with a low debt-to-equity ratio of 0.03, indicating minimal leverage and financial risk. The return on equity is 9.71%, reflecting decent profitability relative to shareholder equity. The equity ratio stands at 83.23%, showcasing a strong capital structure with significant equity backing.
Cash Flow
70
Positive
While the operating cash flow to net income ratio is healthy at 0.65, indicating good cash generation relative to earnings, the free cash flow growth has declined by 62.47%. The free cash flow to net income ratio of 0.84 suggests that the company is generating sufficient cash to cover its net income, but the decline in free cash flow growth is a concern.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue86.00M86.00M62.21M79.88M70.66M60.51M
Gross Profit26.17M26.17M16.86M23.74M21.66M18.24M
EBITDA11.78M12.24M3.98M10.01M11.66M10.23M
Net Income7.01M7.01M1.51M6.21M7.13M6.00M
Balance Sheet
Total Assets86.80M86.80M84.39M86.20M90.77M78.73M
Cash, Cash Equivalents and Short-Term Investments8.68M8.68M12.26M9.44M10.11M9.09M
Total Debt2.42M2.42M10.39M11.71M12.08M14.19M
Total Liabilities14.57M14.57M17.32M19.05M27.73M20.32M
Stockholders Equity72.23M72.23M67.07M67.15M63.04M58.42M
Cash Flow
Free Cash Flow6.95M6.95M6.13M5.10M4.51M6.40M
Operating Cash Flow8.29M8.29M8.45M6.74M5.93M8.23M
Investing Cash Flow-1.34M-1.34M-2.97M-2.53M-1.43M-1.83M
Financing Cash Flow-10.52M-10.52M-2.66M-4.88M-3.49M-6.55M

Clover Corporation Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.84
Price Trends
50DMA
0.70
Positive
100DMA
0.62
Positive
200DMA
0.54
Positive
Market Momentum
MACD
0.05
Negative
RSI
71.24
Negative
STOCH
92.46
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CLV, the sentiment is Positive. The current price of 0.84 is above the 20-day moving average (MA) of 0.74, above the 50-day MA of 0.70, and above the 200-day MA of 0.54, indicating a bullish trend. The MACD of 0.05 indicates Negative momentum. The RSI at 71.24 is Negative, neither overbought nor oversold. The STOCH value of 92.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CLV.

Clover Corporation Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
AU$116.06M16.5510.07%2.06%38.25%361.54%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
AU$134.12M24.1913.97%28.66%
45
Neutral
AU$23.34M-5.75-29.43%102.21%69.47%
43
Neutral
AU$27.14M35.226.76%
38
Underperform
€27.50M-20.54%13.92%36.28%
31
Underperform
AU$4.07M-0.58-21.84%79.99%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:CLV
Clover Corporation Limited
0.82
0.36
77.87%
AU:AHF
Australian Dairy Nutritionals Group
0.04
>-0.01
-22.22%
AU:BUB
Bubs Australia Ltd.
0.14
0.02
16.67%
AU:NUC
Nuchev Pty Ltd
0.16
0.03
23.08%
AU:HCT
Holista Colltech Limited
0.08
0.07
670.00%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
-0.03
-52.08%

Clover Corporation Limited Corporate Events

Clover Corporation Director Increases Shareholding
Oct 28, 2025

Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring 62,996 ordinary shares through an on-market purchase, increasing her total holdings to 149,028 shares. This transaction, valued at $40,050, reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which could positively impact stakeholder perceptions.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Director Increases Shareholding
Oct 28, 2025

Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 31,000 ordinary shares through an on-market purchase, increasing her total holdings to 86,032 shares. This acquisition reflects a strategic move by the director, potentially signaling confidence in the company’s future performance and stability, which could have positive implications for stakeholders and market perception.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Announces 2025 AGM and Annual Report Release
Oct 16, 2025

Clover Corporation Limited has announced the details of its 2025 Annual General Meeting (AGM), scheduled for November 18, 2025, to be held in a hybrid format allowing both in-person and online participation. The AGM will provide shareholders an opportunity to engage with the company’s board, discuss the company’s performance, and vote on key resolutions. The company has also released its 2025 Annual Report, which is available on its website. The board recommends shareholders vote in favor of resolutions 2 to 6, while abstaining from a recommendation on resolution 1 due to its nature concerning the remuneration report.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Director Increases Shareholding
Oct 14, 2025

Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 14,492 ordinary shares through an on-market purchase, increasing her total holdings to 55,032 shares. This acquisition reflects a continued commitment to the company and may indicate confidence in its future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Announces AGM Date and Director Nomination Deadline
Sep 23, 2025

Clover Corporation Limited has announced its intention to hold its annual general meeting (AGM) on 18 November 2025. The company has set the closing date for director nominations for 6 October 2025, in accordance with its constitution and ASX listing rules. This meeting is significant for stakeholders as it provides an opportunity for the election of directors, which could influence the company’s strategic direction and governance.

The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Limited Announces Annual Report and Board Changes
Sep 22, 2025

Clover Corporation Limited has announced its annual report for the year ended 31 July 2025. The company has undergone changes in its board of directors with the appointment of Ms Fiona Pearse as a Non-Executive Director starting from 1 August 2025. This change in leadership could potentially impact the company’s strategic direction and operations.

The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Achieves Strong FY25 Performance with 38% Revenue Growth
Sep 22, 2025

Clover Corporation Limited reported a strong financial performance for the fiscal year 2025, with a 38% increase in net sales revenue to $86 million and a significant rise in net profit after tax to $7 million. The company’s growth was driven by new product launches and improved operational performance, particularly at its Melody Dairies and Ecuador facilities. Clover’s strategic initiatives, including expanding its distribution model and investing in product development, have positioned it well for future growth. The company declared a final dividend of 1 cent per share, reflecting its robust financial health and cash generation capabilities.

The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Achieves Robust Financial Growth in 2025
Sep 22, 2025

Clover Corporation Limited reported a significant financial improvement for the year ended July 31, 2025, with a 38% increase in total revenue to $86 million and a net profit after tax of $7 million, marking a 601% rise from the previous year. This financial growth reflects the company’s strengthened market position and operational success, benefiting stakeholders through increased dividends and a robust financial outlook.

The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation to Announce FY25 Financial Results and Host Investor Webinar
Sep 15, 2025

Clover Corporation Limited is set to release its FY25 financial results on September 23, 2025, before the market opens. The company will host a webinar on the same day, featuring presentations by the Managing Director and CEO, Peter Davey, and CFO, Andrew Allibon, who will discuss the year’s business activities and highlights. This announcement is part of Clover’s ongoing efforts to engage with investors and stakeholders, reflecting its commitment to transparency and strategic growth in the nutritional ingredients sector.

The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025